Skip to content
POM-V Prescription Required Companion Animal

Merilym 3, Suspension for Injection for Dogs

Active ingredients: Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii

Form

Injection

Species

Dogs

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

04491/3033

What it's used for

Reduction of transmission of and no correlation has been established between a specific level of antibodies and reduction of that leads to the development...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Borrelia afzelii + Borrelia...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Merilym 3, Suspension for Injection for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Reduction of transmission of
and no correlation has been established between a specific level of antibodies and
reduction of
that leads to the development of clinical disease has not been studied.
Onset of immunity: 1 month after primary vaccination.
Duration of immunity: 1 year after primary vaccination.
Method of administration:
Subcutaneous use.
Shake the vial well before use.
Primary vaccination:
Administer two doses separated by an interval of 3 weeks.
Revaccination:
Annual revaccination with a single dose is recommended to maintain immunity
although this schedule has not been investigated.
Vaccination should be carried out prior to periods of increased tick activity, allowing
sufficient time for the immune response to vaccination to develop fully (see section
3.2) prior to expected tick exposure.
Do not use in case of general febrile illness.
Do not use in sick animals that have intercurrent disease, heavy parasitic infestation
and/or are in poor general condition.
Do not use in case of suspected or confirmed clinical Lyme borreliosis.
Do not use in cases of hypersensitivity to the active substances, to the adjuvant or to
any of the excipients.
Dogs:
Rare
(1 to 10 animals / 10 000
animals treated):
Injection site swelling.
Anorexia, lethargy.
Very rare
(<1 animal / 10 000 animals
treated, including isolated
reports):
Injection site swelling.
Elevated temperature.
Hypersensitivity reaction.
1
Up to 7 cm in diameter, for up to 5 days.
Up to 15 cm in diameter.
Transient, up to 1.5°C.
Which may require appropriate symptomatic treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
No information is available on the use of the vaccine in seropositive animals including
those with maternally derived antibodies.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Not applicable.
Special precautions for the protection of the environment:
Not applicable.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.
Protect from light.
Store and transport refrigerated (2 °C – 8 °C).
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance
Same active ingredient

Other Products Containing Borrelia afzelii

These products share the same active ingredient and may be suitable alternatives. Always consult your vet.

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.